These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12463149)

  • 1. Cytokine production in standard hemodialysis with a new polyethersulfone membrane: a cross-over study.
    Memoli B; Bisesti V; Saravo MT; Esposito P; D'Arcangelo R; Nicosia V; Clienti C; Andreucci M; Esposito A; Tetta C
    Contrib Nephrol; 2003; (138):80-7. PubMed ID: 12463149
    [No Abstract]   [Full Text] [Related]  

  • 2. Rationale for the use of a low molecular weight heparin during hemodialysis with polysulphone membrane in uremic patients.
    Moia M; Graziani G; Tenconi PM; Martinelli I; Ponticelli C
    Ann Ital Med Int; 1997; 12(2):67-71. PubMed ID: 9284597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency in hemodialysis with polyethersulfone membrane (DIAPES).
    Locatelli F; Di Filippo S; Manzoni C
    Contrib Nephrol; 2003; (138):55-8. PubMed ID: 12463146
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemofiltration and the middle molecule.
    Henderson LW
    Blood Purif; 1999; 17(4):175-7. PubMed ID: 10494018
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of cytokines and adhesion molecules in stable hemodialysis patients: is there an effect of membrane material?
    Hoffmann U; Fischereder M; Marx M; Schweda F; Lang B; Straub RH; Krämer BK
    Am J Nephrol; 2003; 23(6):442-7. PubMed ID: 14583663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evaluation of cellular and inflammatory response to a new polyethersulfone membrane.
    Stefoni S; Coli L; Cianciolo G; Donati G; Dalmastri V; Orlandi V; D'Addio F; Ramazzotti E
    Contrib Nephrol; 2003; (138):68-79. PubMed ID: 12463148
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction of mononuclear cytokine production in hemodialysis patients treated with steam-sterilized low-flux polysulphone membranes.
    Aucella F; Vigilante M; Grandone E; Colaizzo D; Margaglione M; Modoni S; Orlandini G; Stallone C
    Int J Artif Organs; 1998 Apr; 21(4):210-5. PubMed ID: 9649062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodiafiltration and high-flux hemodialysis with polyethersulfone membranes.
    David S; Gerra D; De Nitti C; Bussolati B; Teatini U; Longhena GR; Guastoni C; Bellotti N; Combarnous F; Tetta C
    Contrib Nephrol; 2003; (138):43-54. PubMed ID: 12463145
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial.
    Kerr PG; Sutherland WH; de Jong S; Vaithalingham I; Williams SM; Walker RJ
    Am J Kidney Dis; 2007 Apr; 49(4):533-9. PubMed ID: 17386321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyethersulfone as a high-performance membrane.
    Krieter DH; Lemke HD
    Contrib Nephrol; 2011; 173():130-136. PubMed ID: 21865785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural features of polyethersulfone membranes.
    Ballestri M; Martino C; Tonelli M; Inguaggiato P; Albertazzi A
    Contrib Nephrol; 2003; (138):13-26. PubMed ID: 12463142
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of membrane composition on cytokine production and clinical symptoms during hemodialysis: a crossover study.
    Singh NP; Bansal R; Thakur A; Kohli R; Bansal RC; Agarwal SK
    Ren Fail; 2003 May; 25(3):419-30. PubMed ID: 12803505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A heparin-coated dialysis filter (AN69 ST) does not reduce clotting during hemodialysis when compared to a conventional polysulfone filter (F×8).
    Sagedal S; Witczak BJ; Osnes K; Hartmann A; Os I; Eikvar L; Klingenberg O; Brosstad F
    Blood Purif; 2011; 32(3):151-5. PubMed ID: 21659742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amembris: a new fiber for optimal clearance of a wide spectrum of middle molecules].
    G Ital Nefrol; 2013; 30(2):. PubMed ID: 25077343
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in plasma concentrations of hypoxanthine and uric acid before and after hemodialysis.
    Shahbazian H; Zand Moghadam A; Ehsanpour A; Khazaali M
    Iran J Kidney Dis; 2009 Jul; 3(3):151-5. PubMed ID: 19617664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.
    Krieter DH; Hackl A; Rodriguez A; Chenine L; Moragues HL; Lemke HD; Wanner C; Canaud B
    Nephrol Dial Transplant; 2010 Jan; 25(1):212-8. PubMed ID: 19755476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a new polyamide membrane (Polyflux 130) in high-flux dialysis.
    Schaefer RM; Gilge U; Goehl H; Heidland A
    Blood Purif; 1990; 8(1):23-31. PubMed ID: 2198889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrolyte dialysance using a polyethersulfone membrane (DIAPES) in relation to urea clearance.
    Di Filippo S; Manzoni C; Locatelli F
    Contrib Nephrol; 2003; (138):106-9. PubMed ID: 12463152
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemodialysis without heparin: a randomized, controlled, crossover study of two dialysis membranes (AN69ST and polysulfone F60).
    Brunet P; Frances J; Vacher-Coponat H; Jaubert D; Lebrun G; Gondouin B; Duval A; Berland Y
    Int J Artif Organs; 2011 Dec; 34(12):1165-71. PubMed ID: 22198602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.